David Weinshenker Selected Research

Dopamine D3 Receptors

1/2019

Selective D2 and D3 receptor antagonists oppositely modulate cocaine responses in mice via distinct postsynaptic mechanisms in nucleus accumbens.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David Weinshenker Research Topics

Disease

12	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 01/2013
11	Cognitive Dysfunction 11/2023 - 01/2013
9	Cocaine-Related Disorders (Cocaine Addiction) 01/2017 - 10/2006
9	Epilepsy (Aura) 01/2016 - 06/2002
7	Seizures (Absence Seizure) 02/2023 - 04/2006
6	Parkinson Disease (Parkinson's Disease) 03/2023 - 01/2016
5	Disease Progression 01/2020 - 11/2017
5	Substance-Related Disorders (Drug Abuse) 01/2019 - 10/2006
4	Neuroinflammatory Diseases 06/2023 - 01/2018
4	Schizophrenia (Dementia Praecox) 01/2019 - 03/2005
3	Pain (Aches) 03/2023 - 01/2002
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 01/2020
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2024 - 01/2020
2	Opioid-Related Disorders (Opiate Addiction) 03/2023 - 10/2021
2	Status Epilepticus (Complex Partial Status Epilepticus) 02/2023 - 12/2012
2	Prodromal Symptoms 01/2023 - 01/2023
2	Dementia (Dementias) 01/2023 - 01/2016
2	Infections 01/2016 - 03/2010
2	Hypersensitivity (Allergy) 01/2016 - 10/2006
2	Memory Disorders (Memory Loss) 02/2014 - 01/2013
2	Alcoholism (Alcohol Abuse) 01/2012 - 08/2009
2	Psychotic Disorders (Schizoaffective Disorder) 09/2006 - 03/2005
1	Wounds and Injuries (Trauma) 07/2023
1	Obesity 06/2023
1	Neurobehavioral Manifestations 06/2023
1	Inflammation (Inflammations) 01/2022
1	Catalepsy 10/2021
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2021
1	Shock 01/2021
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 07/2020
1	Gliosis 01/2020
1	Galactosemias (Galactosemia) 01/2020
1	Amyloid Plaque 10/2019
1	Tauopathies 01/2018
1	Gambling (Pathological Gambling) 01/2018
1	Frontotemporal Dementia (Semantic Dementia) 10/2017

Drug/Important Bio-Agent (IBA)

22	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2024 - 01/2002
11	Dopamine (Intropin)FDA LinkGeneric 03/2023 - 01/2002
10	Amyloid (Amyloid Fibrils)IBA 06/2023 - 01/2013
9	Cocaine (Cocaine HCl)IBA 01/2017 - 10/2006
8	Disulfiram (Antabuse)FDA Link 01/2018 - 10/2006
8	Dopamine beta-HydroxylaseIBA 03/2010 - 01/2002
7	EnzymesIBA 01/2020 - 01/2002
5	Amyloid beta-PeptidesIBA 11/2023 - 01/2013
5	Proteins (Proteins, Gene)FDA Link 06/2023 - 06/2014
5	Biomarkers (Surrogate Marker)IBA 01/2023 - 09/2006
4	CatecholaminesIBA 01/2023 - 06/2002
4	Opioid Analgesics (Opioids)IBA 10/2021 - 01/2002
4	GalaninIBA 01/2021 - 10/2013
4	Antidepressive Agents (Antidepressants)IBA 10/2013 - 04/2006
3	Presenilin-1IBA 06/2023 - 06/2014
3	NeurotoxinsIBA 01/2023 - 10/2015
3	Morphine (MS Contin)FDA LinkGeneric 10/2021 - 01/2002
3	Mixed Function Oxygenases (Monooxygenases)IBA 01/2016 - 11/2010
3	Anticonvulsants (Antiepileptic Drugs)IBA 10/2013 - 04/2006
3	Flurothyl (Flurotyl)IBA 07/2013 - 04/2006
3	Amphetamine (Amfetamine)FDA LinkGeneric 09/2006 - 10/2002
2	neuromelaninIBA 01/2024 - 01/2022
2	Epinephrine (Adrenaline)FDA LinkGeneric 07/2023 - 01/2016
2	Adrenergic Agents (Adrenergic Drugs)IBA 07/2023 - 01/2016
2	Kainic Acid (Kainate)IBA 02/2023 - 05/2007
2	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 01/2023 - 01/2022
2	Levodopa (L Dopa)FDA LinkGeneric 01/2023 - 10/2015
2	SynucleinsIBA 01/2023 - 01/2020
2	DSP 4 (DSP-4)IBA 01/2023 - 01/2018
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2016 - 01/2002
2	Pilocarpine (Ocusert)FDA LinkGeneric 10/2013 - 12/2012
2	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 09/2006 - 03/2005
2	Ethanol (Ethyl Alcohol)IBA 09/2006 - 03/2005
2	Phencyclidine (Angel Dust)IBA 09/2006 - 03/2005
2	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 09/2006 - 03/2005
1	salicylhydroxamic acid (SHAM)IBA 07/2023
1	CholesterolIBA 06/2023
1	SugarsIBA 06/2023
1	Methadone (Dolophine)FDA LinkGeneric 03/2023
1	Opioid Receptors (Opioid Receptor)IBA 03/2023
1	Monophenol Monooxygenase (Tyrosinase)IBA 01/2023
1	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 01/2022
1	AZD4694IBA 01/2022
1	OsteoprotegerinIBA 01/2022
1	CytokinesIBA 01/2022
1	N- (4- (4- (2,3- dichlorophenyl)piperazin- 1- yl)but- 2- enyl)- 4- pyridine- 2- ylbenzamideIBA 10/2021
1	Apolipoprotein E4IBA 01/2021
1	Naloxone (Narcan)FDA LinkGeneric 01/2021
1	Type 1 Galanin ReceptorIBA 01/2021
1	NeuropeptidesIBA 01/2021
1	Apolipoprotein E3IBA 01/2021
1	Galactose (Galactopyranose)FDA LinkGeneric 01/2020
1	Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA 01/2020
1	galactose-1-phosphateIBA 01/2020
1	Serine (L-Serine)FDA Link 10/2019
1	serine racemaseIBA 10/2019
1	Dopamine D3 ReceptorsIBA 01/2019
1	Protein AggregatesIBA 10/2017
1	beta-Arrestin 1IBA 01/2017
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2016

Therapy/Procedure

8	Drug Therapy (Chemotherapy) 01/2020 - 10/2006
5	Therapeutics 01/2023 - 12/2012
2	Analgesia 05/2009 - 01/2002
2	Ketogenic Diet 11/2008 - 03/2006